Literature DB >> 11426944

HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways.

R Warn1, P Harvey, A Warn, A Foley-Comer, P Heldin, M Versnel, N Arakaki, Y Daikuhara, G J Laurent, S E Herrick, S E Mutsaers.   

Abstract

Mesothelial repair differs from that of other epithelial-like surfaces as healing does not occur solely by centripetal in-growth of cells as a sheet from the wound margins. Mesothelial cells lose their cell-cell junctions, divide, and adopt a fibroblast-like morphology while scattering across and covering the wound surface. These features are consistent with a cellular response to hepatocyte growth factor/scatter factor (HGF/SF). In this study, we examined the ability of mesothelial cells to secrete HGF/SF and investigated its possible role as an autocrine regulator of mesothelial cell motility and proliferation. We found that human primary mesothelial cells expressed HGF/SF mRNA and secreted active HGF/SF into conditioned medium as determined by ELISA and in a scattering bioassay. These cells also expressed the HGF/SF receptor, Met, as shown by RT-PCR and by Western blot analysis and immunofluorescence. Incubation of mesothelial cells with neutralizing antibodies to HGF/SF decreased cell migration to 25% of controls, whereas addition of HGF/SF disrupted cell-cell junctions and induced scattering and enhanced mesothelial cell migration. Furthermore, HGF/SF showed a small but significant mitogenic effect on all mesothelial cell lines examined. In conclusion, HGF/SF is produced by mesothelial cells and induces both motility and proliferation of these cells. These data are consistent with HGF/SF playing an autocrine role in mesothelial healing. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11426944     DOI: 10.1006/excr.2001.5240

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

Review 1.  Pathophysiology and prevention of postoperative peritoneal adhesions.

Authors:  Willy Arung; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

Review 2.  Current treatment options for colon cancer peritoneal carcinomatosis.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Stimulation of mesothelial cell proliferation by exudate macrophages enhances serosal wound healing in a murine model.

Authors:  Steven E Mutsaers; Darrel Whitaker; John M Papadimitriou
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 4.  Regenerative Medicine Therapies for Prevention of Abdominal Adhesions: A Scoping Review.

Authors:  Samuel P Carmichael; Jaewook Shin; John W Vaughan; Prafulla K Chandra; John B Holcomb; Anthony J Atala
Journal:  J Surg Res       Date:  2022-03-17       Impact factor: 2.417

Review 5.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

Review 6.  Peritoneal adipocytes and their role in inflammation during peritoneal dialysis.

Authors:  Kar Neng Lai; Joseph C K Leung
Journal:  Mediators Inflamm       Date:  2010-05-05       Impact factor: 4.711

7.  Attenuated Salmonella typhimurium carrying the hepatocyte growth factor and keratinocyte growth factor genes repairs gastrointestinal mucosal damage caused by chemotherapy.

Authors:  Jun-Zhong Sun; Xiao-Qin Ha; Li-Ming Zhang; Hai-Bin Wang; Hong-Wei Wang; Hai-Feng Duan
Journal:  Med Oncol       Date:  2013-01-19       Impact factor: 3.064

Review 8.  The role of hepatocyte growth factor in corneal wound healing.

Authors:  Hidetaka Miyagi; Sara M Thomasy; Paul Russell; Christopher J Murphy
Journal:  Exp Eye Res       Date:  2017-10-10       Impact factor: 3.467

9.  Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Bipolar Disorder Normalizes after Zinc and Anti-oxidant Therapy.

Authors:  A J Russo
Journal:  Nutr Metab Insights       Date:  2010-10-19

Review 10.  Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis.

Authors:  Hans-Theo Schon; Matthias Bartneck; Erawan Borkham-Kamphorst; Jacob Nattermann; Twan Lammers; Frank Tacke; Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-02-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.